Active-ingredient Dossier
Pneumococcal Purified Capsular Polysaccharides
Active-ingredient Dossier for Pneumococcal Purified Capsular Polysaccharides (pneumococcal vaccine). Australian brands, products, PBS listings, PBAC…
- Brand: CAPVAXIVE
- Brand: VAXNEUVANCE
- Brand: Prevenar
- Brand: PNEUMOVAX
- Therapeutic area: Infectious Disease
What is
Pneumococcal Purified Capsular Polysaccharides Pneumococcal Purified Capsular Polysaccharides is a pneumococcal vaccine.
Australian brands containing
Pneumococcal Purified Capsular Polysaccharides — CAPVAXIVE — VAXNEUVANCE — Prevenar — PNEUMOVAX
Therapeutic areas
Pneumococcal Purified Capsular Polysaccharides is registered in three therapeutic areas: Infectious Disease (2 brands), Immunology (1 brand), and Oncology (1 brand).
Sponsor landscape
Two sponsors market Pneumococcal Purified Capsular Polysaccharides: Merck Sharp & Dohme and Pfizer.
PBS and regulatory activity
Three brands have PBAC outcomes on record, with the latest outcome dated 1 November 2024. Two brands have AusPARs on record, with the latest dated 30 January 2025.